Nexus AG (CHIX:NXUD) ROCE %: 10.95% (As of Sep. 2025)


CHIX:NXUD Nexus AG CHIX:NXUD
78 GF Score
Price €68.60
GF Value €71.37
! 5 Warning Signs
View Full Analysis

What is Nexus AG ROCE %?

Nexus AG CHIX:NXUD 78 ROCE % is 10.95% as of Sep. 2025. GuruFocus rates CHIX:NXUD with a GF Score™ of 78/100 and a GF Value™ of €71.37. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nexus AG's annualized ROCE % for the quarter that ended in Sep. 2025 was 10.95%.


Nexus AG  (CHIX:NXUd) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Nexus AG ROCE % Related Terms


Nexus AG ROCE % Historical Data

* Premium members only.

The historical data trend for Nexus AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexus AG ROCE % Chart

Nexus AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.09 13.53 12.15 11.56 12.62

Nexus AG Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.86 14.46 13.92 12.32 10.95
CHIX:NXUD
78GF Score
Nexus AG CHIX:NXUD
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexus AG ROCE % Calculation

Nexus AG's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=42.465/( ( (411.716 - 86.423) + (437.733 - 90.284) )/ 2 )
=42.465/( (325.293+347.449)/ 2 )
=42.465/336.371
=12.62 %

Nexus AG's ROCE % of for the quarter that ended in Sep. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=41.648/( ( (478.186 - 105.37) + (489.721 - 101.783) )/ 2 )
=41.648/( ( 372.816 + 387.938 )/ 2 )
=41.648/380.377
=10.95 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.95% mean?
Nexus AG (CHIX:NXUD) has a ROCE % of 10.95% as of Sep. 2025.
Is Nexus AG's ROCE % too high?
Nexus AG's current ROCE % is 10.95%. The Healthcare Providers & Services industry median ROCE % is 6.41. Nexus AG's value of 10.95% is 70.8% above this industry median. Overall, Nexus AG has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Nexus AG's ROCE % compare to VEEV and GEHC?
Nexus AG's ROCE % of 10.95% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Nexus AG's value of 10.95% is 70.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexus AG's current ROCE % of 10.95% is 70.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus AG's current ROCE % is 10.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus AG stock overvalued right now?
Nexus AG (CHIX:NXUD) has a current ROCE % of 10.95%. The stock's GF Value™ is €71.37, compared to a current price of €68.60 — trading 3.9% below its estimated fair value. The current ROCE % is 10.95% and 70.8% above the Healthcare Providers & Services industry median of 6.41. Nexus AG's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nexus AG (CHIX:NXUD), the current ROCE % is 10.95% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexus AG (CHIX:NXUD) Overvalued in 2026?

Based on GuruFocus' analysis, Nexus AG stock appears to be undervalued. The current stock price of €68.60 is trading 3.9% below its estimated GF Value™ of €71.37.

Key valuation signals for CHIX:NXUD:

  • ROCE %: 10.95%
  • GF Value™: €71.37 vs. price of €68.60 (3.9% below fair value)
  • GF Score™: 78/100 with 5 warning signs
  • Industry Position: 70.8% above the Healthcare Providers & Services median

No single metric tells the full story. See the CHIX:NXUD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nexus AG Business Description

Address Irmastrasse 1, Donaueschingen, BW, DEU, 78166
Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations especially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
78GF Score

Get the complete analysis for CHIX:NXUD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.60
Price
€71.37
GF Value